Clinical Trials Directory

Trials / Conditions / Myeloma, Plasma-Cell

Myeloma, Plasma-Cell

10 registered clinical trials studyying Myeloma, Plasma-Cell.

StatusTrialSponsorPhase
TerminatedStudy of BMF-219, a Covalent Menin Inhibitor, in Adult Patients With AML, ALL (With KMT2A/ MLL1r, NPM1 Mutatio
NCT05153330
Biomea Fusion Inc.Phase 1
Active Not RecruitingStudy of Selinexor Plus DRd for Newly Diagnosed Multiple Myeloma
NCT04782687
US Oncology ResearchPhase 2
CompletedT-cells Expressing an Anti-SLAMF7 CAR for Treating Multiple Myeloma
NCT03958656
National Cancer Institute (NCI)Phase 1
Active Not RecruitingT Cells Expressing a Novel Fully-Human Anti-BCMA CAR for Treating Multiple Myeloma
NCT03602612
National Cancer Institute (NCI)Phase 1
CompletedCarfilzomib in Combination With Daratumumab, Lenalidomide and Dexamethasone in Transplant-ineligible NDMM Pati
NCT04065789
Tel-Aviv Sourasky Medical CenterPhase 2
CompletedStudy of T Cells Targeting B-Cell Maturation Antigen for Previously Treated Multiple Myeloma
NCT02215967
National Cancer Institute (NCI)Phase 1
TerminatedTh1/Tc1 Immunotherapy Following Stem Cell Transplantation in Multiple Myeloma
NCT01239368
National Cancer Institute (NCI)Phase 1 / Phase 2
CompletedMulti-day Doses in Prevention of Nausea and Emesis
NCT00600353
University of Kansas Medical CenterPhase 2
CompletedPhase I/II Study of hLL1 in Multiple Myeloma
NCT00421525
Gilead SciencesPhase 1 / Phase 2
CompletedLow-Intensity Preparation and Allogeneic Transplant in Patients With Cancers of the Blood
NCT00146055
University of Michigan Rogel Cancer CenterPhase 2